Drug intelligence / Profile preview

Small Mobile stem cell therapy

Development stage: Unknown
Lead developer: SMSbiotech
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous (inferred Based On Typical Administration Route For Systemic Stem Cell Therapies)

Overview

Small Mobile stem cell therapy is a novel investigational regenerative medicine product developed by Smsbiotech. It utilizes a proprietary population of "small mobile stem cells" (SMS cells), which are designed to promote tissue repair and regeneration. The primary mechanism involves the administration of these specialized stem cells to modulate inflammation, support tissue healing, and potentially restore function in damaged organs. The initial clinical focus is on chronic obstructive pulmonary disease (COPD), with the goal of improving lung function and reducing disease progression.

Other names: SMS cell therapysmall mobile stem (SMS) cell therapy

Beyond the preview

Go deeper on Small Mobile stem cell therapy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small Mobile stem cell therapy.

Explore the full profile